Proprietary platform is built on one of the largest multimodal oncology datasets, including 250,000+ tumor exomes, 1 million+ plasma timepoints,…
Research seeks to advance discovery and development of treatments for ALS LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The ALS…
Edge vision + multimodal, multi-model orchestration deliver real-time, hyper-personalized support at the bedside BERKELEY, Calif., Aug. 21, 2025 /PRNewswire/ --…
In this free webinar, learn how enhanced precision and efficiency through advanced AI tools enable rapid and accurate design of…
BOSTON, Aug. 20, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today…
Oslo, Norway, 20 August 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies…
Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing tissue-based diagnostic test…
Empowering Emerging Leaders Through Research-Backed Training and Measurable Growth CONCORD, Calif., Aug. 19, 2025 /PRNewswire/ -- Center for Social Dynamics…
PLANO, Texas, Aug. 19, 2025 /PRNewswire/ -- StaffDNA today unveiled a powerful new document storage and management platform designed to transform…
RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2025 /PRNewswire/ -- Calidar, Inc., an innovative start-up in precision diagnostic imaging, today announced…